Public-private partnerships can help advance global health goals

"Three people die every minute from tuberculosis [TB] -- a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company (BD), writes in the Harvard Business Review Blog Network. "Without adequate financing, ministries of health and even private hospitals in developing countries often don't have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment," he notes, and asks, "What can the health care industry do to help fight disease, while still maintaining its commitments to shareholders?" Forlenza discusses some of the public-private partnerships of BD and outlines several lessons learned from the programs, which he says he "hope[s] will serve us and others as we continue to try to transform health care systems in Africa, India, and beyond." He concludes, "Today's health care marketplace calls for global problem solvers, not just products, and that is something we should all strive for -- together" (5/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Air pollution spikes drive unnecessary antibiotic use, fueling resistance